Shopping Cart 0
Cart Subtotal
AED 0

Axcella Health Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Axcella Health Inc (Axcella), formerly Pronutria Biosciences Inc is a developer of disease-specific amino acid profiles. The company's lead clinical-stage candidates AXA are based on cell-specific sets of amino acids that regulate multiple biological pathways. Its amino acid therapies helps in treating orphan diseases in muscle, neurological, metabolic and liver settings, which include myotonic dystrophy, intractable epilepsy syndromes, pediatric nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, sarcopenia and other disease populations. Axcella conducts human signal seeking and confirming studies to understand the impact of various AXA candidates on human liver biology. The company uses a proprietary platform to identify the amino acid profile associated with a medical condition and de-risk the clinical development process. Axcella is headquartered in Cambridge, Massachusetts, the US.

Axcella Health Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Axcella Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Axcella Health Inc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Pronutria Raises USD39 Million in Series C Financing 10

Pronutria Raises USD28.3 Million in Venture Financing 11

Pronutria Raises USD 12.3 Million In Series B Financing 12

Axcella Health (Pronutria Biosciences) Secures USD12.25 Million in Series B Funding Round 13

Pronutria Raises USD 10.8 Million In Series A Financing 14

Partnerships 15

KineMed Enters into R&D Agreement with Pronutria Biosciences 15

Equity Offering 16

Pronutria Biosciences Raises USD42.5 Million in Equity Investment 16

Axcella Health Inc-Key Competitors 17

Axcella Health Inc-Key Employees 18

Axcella Health Inc-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Corporate Communications 20

Oct 22, 2018: Axcella appoints Stephen Mitchener, PharmD, to senior vice president, chief business officer 20

Jun 27, 2018: Axcella Welcomes William D. Baird, and Cristina M. Rondinone to Board of Directors 21

May 31, 2018: Axcella Health Names Bill Hinshaw as President and Chief Executive Officer 23

Jan 03, 2018: Axcella Announces Appointment of David Epstein, Former CEO of Novartis Pharmaceuticals, as Chairman of its Board of Directors 24

Sep 14, 2017: Axcella Appoints Manu Chakravarthy, M.D., Ph.D., as Chief Medical Officer 25

Jun 14, 2017: Axcella Appoints Tony Tramontin, Ph.D., as Senior Vice President, Chief Scientific Officer 26

May 11, 2017: Axcella Announces the Appointment of Ivana Magovcevic-Liebisch, Ph.D., J.D., as Executive Vice President, Chief Strategy and Corporate Development Officer 27

Jan 03, 2017: Axcella Augments Leadership Team with the Appointment of Three Key Hires 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Axcella Health Inc, Pharmaceuticals & Healthcare, Key Facts 2

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Axcella Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Axcella Health Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Pronutria Raises USD39 Million in Series C Financing 10

Pronutria Raises USD28.3 Million in Venture Financing 11

Pronutria Raises USD 12.3 Million In Series B Financing 12

Axcella Health (Pronutria Biosciences) Secures USD12.25 Million in Series B Funding Round 13

Pronutria Raises USD 10.8 Million In Series A Financing 14

KineMed Enters into R&D Agreement with Pronutria Biosciences 15

Pronutria Biosciences Raises USD42.5 Million in Equity Investment 16

Axcella Health Inc, Key Competitors 17

Axcella Health Inc, Key Employees 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Axcella Health Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Axcella Health Inc (Axcella), formerly Pronutria Biosciences Inc is a developer of disease-specific amino acid profiles. The company's lead clinical-stage candidates AXA are based on cell-specific sets of amino acids that regulate multiple biological pathways. Its amino acid therapies helps in treating orphan diseases in muscle, neurological, metabolic and liver settings, which include myotonic dystrophy, intractable epilepsy syndromes, pediatric nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, sarcopenia and other disease populations. Axcella conducts human signal seeking and confirming studies to understand the impact of various AXA candidates on human liver biology. The company uses a proprietary platform to identify the amino acid profile associated with a medical condition and de-risk the clinical development process. Axcella is headquartered in Cambridge, Massachusetts, the US.

Axcella Health Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Axcella Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Axcella Health Inc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Pronutria Raises USD39 Million in Series C Financing 10

Pronutria Raises USD28.3 Million in Venture Financing 11

Pronutria Raises USD 12.3 Million In Series B Financing 12

Axcella Health (Pronutria Biosciences) Secures USD12.25 Million in Series B Funding Round 13

Pronutria Raises USD 10.8 Million In Series A Financing 14

Partnerships 15

KineMed Enters into R&D Agreement with Pronutria Biosciences 15

Equity Offering 16

Pronutria Biosciences Raises USD42.5 Million in Equity Investment 16

Axcella Health Inc-Key Competitors 17

Axcella Health Inc-Key Employees 18

Axcella Health Inc-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Corporate Communications 20

Oct 22, 2018: Axcella appoints Stephen Mitchener, PharmD, to senior vice president, chief business officer 20

Jun 27, 2018: Axcella Welcomes William D. Baird, and Cristina M. Rondinone to Board of Directors 21

May 31, 2018: Axcella Health Names Bill Hinshaw as President and Chief Executive Officer 23

Jan 03, 2018: Axcella Announces Appointment of David Epstein, Former CEO of Novartis Pharmaceuticals, as Chairman of its Board of Directors 24

Sep 14, 2017: Axcella Appoints Manu Chakravarthy, M.D., Ph.D., as Chief Medical Officer 25

Jun 14, 2017: Axcella Appoints Tony Tramontin, Ph.D., as Senior Vice President, Chief Scientific Officer 26

May 11, 2017: Axcella Announces the Appointment of Ivana Magovcevic-Liebisch, Ph.D., J.D., as Executive Vice President, Chief Strategy and Corporate Development Officer 27

Jan 03, 2017: Axcella Augments Leadership Team with the Appointment of Three Key Hires 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Axcella Health Inc, Pharmaceuticals & Healthcare, Key Facts 2

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Axcella Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Axcella Health Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Pronutria Raises USD39 Million in Series C Financing 10

Pronutria Raises USD28.3 Million in Venture Financing 11

Pronutria Raises USD 12.3 Million In Series B Financing 12

Axcella Health (Pronutria Biosciences) Secures USD12.25 Million in Series B Funding Round 13

Pronutria Raises USD 10.8 Million In Series A Financing 14

KineMed Enters into R&D Agreement with Pronutria Biosciences 15

Pronutria Biosciences Raises USD42.5 Million in Equity Investment 16

Axcella Health Inc, Key Competitors 17

Axcella Health Inc, Key Employees 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Axcella Health Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.